Neurolief
Netanya
About Neurolief
Neurolief is a neuromodulation company dedicated to bringing relief to patients suffering from mental health and neurological disorders. The company consists of highly experienced professionals with a proven track record in neuroscience, neuromodulation technology, and the neurotech industry. Neurolief has developed a disruptive platform technology, the world's first and only non-invasive, multi-channel brain neuromodulation system designed to concurrently neuromodulate major neural pathways in the head and thereby affect brain regions involved in the control and modulation of mood and pain.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.0M
- Last round: Convertible Note (Mar 2026)
- Website: neurolief.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Medical Device, Mental Health, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neurolief-24979 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.